By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today announced it has extended its tender offer to acquire all outstanding shares of Illumina.

The offer is now set to expire March 23 at 6 p.m. EST. It had been scheduled to expire at the end of the day Feb. 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.